Video interview with patient with childhood asthma and ABPA, who showed a marked improvement in her ABPA and asthma when she commenced nebulised Amphotericin B. Her medication was changed from itraconazole at this time to allow for her to try for pregnancy. Two types of nebuliser – VentStream and the Pari LC system are discussed in the interview. Her condition is still stable using inhaled amphotericin B. We thank the patient for kindly providing this interview
Share this post
Latest News posts
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
Walk and paint yourself back to health & wellbeing
October 14, 2021
Antifungal Drug Pipeline
October 8, 2021
Is it COVID or just a cold?
September 24, 2021
World Sepsis Day 2021
September 13, 2021
Aspergillosis and Depression: A Personal Reflection
September 1, 2021
Therapeutic drug monitoring (TDM)
August 9, 2021
When will there be a vaccine for aspergillosis?
July 16, 2021
Palliative Care – Not What You Might Think
June 15, 2021
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video